Status:
COMPLETED
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This prospective observational study will evaluate the efficacy and safety of bevacizumab in combination with capecitabine and oxaliplatin as first-line treatment in participants with colorectal cance...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 18 years of age
- Metastatic colorectal cancer
- Treatment in accordance with current Summary of Product Characteristics and local guidelines
Exclusion
- Contraindications according to current Summary of Product Characteristics and local guidelines
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01399190
Start Date
July 1 2011
End Date
February 1 2014
Last Update
September 28 2016
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Banská Bystrica, Slovakia, 975 17
2
Bratislava, Slovakia, 812 50
3
Bratislava, Slovakia, 833 10
4
Košice, Slovakia, 04001